Mesenchymal stem cells are enriched in head neck squamous cell carcinoma, correlates with tumour size and inhibit T-cell proliferation

British Journal of Cancer

Volumn 112, Issue 4, 2015, Pages 745-754

  Liotta, F ^a,b   Querci, V ^a   Mannelli, G ^c   Santarlasci, V ^a   Maggi, L ^a   Capone, M ^a   Rossi, M C ^a   Mazzoni, A ^a   Cosmi, L ^a,b   Romagnani, S ^a   Maggi, E ^a,b   Gallo, O ^c   Annunziato, F ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

HNSCC; immunity; immunoregulation; MSCs; tumour

Indexed keywords

5' NUCLEOTIDASE; BETA1 INTEGRIN; CD133 ANTIGEN; CD45 ANTIGEN; DIOXYGENASE; ENDOGLIN; EPITHELIAL MEMBRANE ANTIGEN; INDOELAMINE 2,3 DIOXYGENASE; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADHERENT CELL; ADULT; AGED; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MIDDLE AGED; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR VOLUME; CASE CONTROL STUDY; CELL COUNT; CELL PROLIFERATION; DOWN REGULATION; HEAD AND NECK TUMOR; IMMUNOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA;

AGED; ANTIGENS, THY-1; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL COUNT; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; T-LYMPHOCYTES; TUMOR BURDEN;

EID: 84923631755     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.15     Document Type: Article

References (43)

1. Al-toub M, Almusa A, Almajed M, Al-Nbaheen M, Kassem M, Aldahmash A, Alajez NM. (2013). Pleiotropic effects of cancer cells' secreted factors on human stromal (mesenchymal) stem cells. Stem Cell Res Ther 4: 114
2. Annunziato F, Romagnani S. (2010). The transient nature of the Th17 phenotype. Eur J Immunol 40: 3312-3316
3. Baker KS, DeFor TE, Burns LJ, Ramsay NK, Neglia JP, Robison LL. (2003). New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. J Clin Oncol 21: 1352-1358
4. Baron F, Lechanteur C, Willems E, Bruck F, Baudoux E, Seidel L, Vanbellinghen JF, Hafraoui K, Lejeune M, Gothot A, Fillet G, Beguin Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graftversus- tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biol Blood Marrow Transplant 16: 838-847
5. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30: 42-48
6. Bergfeld SA, DeClerck YA. (2010). Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 29: 249-261
7. Bieback K, Kluter H. (2007). Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2: 310-323
8. Bruno S, Bussolati B, Grange C, Collino F, di Cantogno LV, Herrera MB, Biancone L, Tetta C, Segoloni G, Camussi G. (2009). Isolation and characterization of resident mesenchymal stem cells in human glomeruli. Stem Cells Dev 18: 867-879
9. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, Frosali F, Rodolico G, Querci V, Abbate G, Angeli R, Berrino L, Fambrini M, Caproni M, Tonelli F, Lazzeri E, Parronchi P, Liotta F, Maggi E, Romagnani S, Annunziato F. (2008). Human interleukin-17 producing cells originate from a CD161+ CD4+ T-cell precursor. J Exp Med 205: 1903-1916
10. De Boeck A, Narine K, De Neve W, Mareel M, Bracke M, De Wever O. (2010). Resident and bonemarrow-derived mesenchymal stem cells in head and neck squamous cell carcinoma. Oral Oncol 46: 336-342
11. Dethlefsen LA, Prewitt JM, Mendelsohn ML. (1968). Analysis of tumor growth curves. J Natl Cancer Inst 40: 389-405
12. De Wever O, Demetter P, Mareel M, Bracke M. (2008). Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 123: 2229-2238
13. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Dj Prockop, Horwitz E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317
14. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. (2010). AJCC Cancer Staging Manual 7th edn. XV, 649 p.
15. Finn OJ. (2012). Understanding the function and dysfunction of the immune system in cancer. Ann Oncol 23(Suppl 8): viii6-viii9
16. Flynn A, Barry F, O'Brien T. (2007). UC blood-derived mesenchymal stromal cells: an overview. Cytotherapy 9: 717-726
17. Forastiere A, Koch W, Trotti A, Sidransky D. (2001). Head and neck cancer. N Engl J Med 345: 1890-1900
18. Gucciardo L, Lories R, Ochsenbein-Kölble N, Done' E, Zwijsen A, Deprest J. (2009). Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG 116: 166-172
19. Hall B, Andreeff M, Marini F. (2007). The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles. Handb Exp Pharmacol 180: 263-283
20. Harris JP, Penn I. (1981). Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 91: 520-528
21. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, Deans RJ, Krause DS, Keating A. (2005). Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395
22. Hu J, Zhou Z, Shi S, Zhu X, Wang X, Zhang W, Hu S, Qian H, Xu W. (2013). Mesenchymal stem-like cells isolated from human esophageal carcinoma and adjacent non-cancerous tissues. Oncol Lett 5: 179-184
23. In't Anker PS, Scherjon SA, Kleijburg-van Der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE, Kanhai HH. (2003). Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102: 1548-1549
24. Kansy BA, Dímann PA, Hemeda H, Bruderek K, Westerkamp AM, Jagalski V, Schuler P, Kansy K, Lang S, Dumitru CA, Brandau S. (2014). The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther 5: 95
25. King GN, Healy CM, Glover MT, Kwan JT, Williams DM, Leigh IM, Worthington HV, Thornhill MH. (1995). Increased prevalence of dysplastic and malignant lip lesions in renal-transplant recipients. N Engl J Med 332: 1052-1057
26. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F. (2006). Role for IFN-g in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24(2): 386-398
27. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O. (2004). Treatment of severe graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441
28. Ling W, Zhang J, Yuan Z, Ren G, Zhang L, Chen X, Rabson AB, Roberts AI, Wang Y, Shi Y. (2014). Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res 74: 1576-1587
29. Lin TM, Chang HW,Wang KH, Kao AP, Chang CC, Wen CH, Lai CS, Lin SD. (2007). Isolation and identification of mesenchymal stem cells from human lipoma tissue. Biochem Biophys Res Commun 361: 883-889
30. Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F. (2008). TLR3 and TLR4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signalling. Stem Cells 26: 279-289
31. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. (2008). Carcinoma-associated fibroblastlike differentiation of human mesenchymal stem cells. Cancer Res 68: 4331-4339
32. Mitrano TI, Grob MS, Carrión F, Nova-Lamperti E, Luz PA, Fierro FS, Quintero A, Chaparro A, Sanz A. (2010). Culture and characterization of mesenchymal stem cells from human gingival tissue. J Periodontol 81: 917-925
33. Murphy KM, Stockinger B. (2010). Effector T cell plasticity: flexibility in the face of changing circumstances. Nat Immunol 11: 674-680
34. Nakahara H, Dennis JE, Bruder SP, Haynesworth SE, Lennon DP, Caplan AI. (1991). In vitro differentiation of bone and hypertrophic cartilage from periosteal-derived cells. Exp Cell Res 195: 492-503
35. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S, Yasunaga Y. (2004). Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofi bers. Tissue Eng 10: 1093-1112
36. Rajantie I, Ilmonen M, Alminaite A, Ozerdem U, Alitalo K, Salven P. (2004). Adult bone marrow- derived cells recruited during angiogenesis comprise precursors for periendothelial vascular mural cells. Blood 104: 2084-2086
37. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, Brigham KL. (2005). Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 33: 145-152
38. Schüring AN, Schulte N, Kelsch R, Röpke A, Kiesel L, Götte M. (2011). Characterization of endometrial mesenchymal stem-like cells obtained by endometrial biopsy during routine diagnostics. Fertil Steril 95: 423-426
39. Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F. (2009). Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4(4): e4992
40. Sturgis EM, Cinciripini PM. (2007). Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?. Cancer 110: 1429-1435
41. Sun X, Cai H, Qian H, Zhu W, Yan Y, Xu H, Xu W(2011) Mesenchymal stem cells isolated from human uterine cervix cancer tissues. Cell Biol Int 35: 119-123
42. Xu X, Zhang X, Wang S, Qian H, Zhu W, Cao H, Wang M, Chen Y, Xu W. (2011). Isolation and comparison of mesenchymal stem-like cells from human gastric cancer and adjacent non-cancerous tissues. J Cancer Res Clin Oncol 137: 495-504
43. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 13: 4279-4295